Virus like particle cancer vaccine - VLP Therapeutics
Alternative Names: i-αVLP vaccine - VLP TherapeuticsLatest Information Update: 11 Aug 2021
At a glance
- Originator VLP Therapeutics
- Class Antineoplastics; Cancer vaccines; Immunotherapies; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer